Feedback / Questions
mirodenafil (AR1001) - ariBio, Samjin Pharma
https://www.businesswire.com/news/home/20240513108742/en/AriBio-Receives-IND-Approval-from-China%E2%80%99s-NMPA-for-POLARIS-AD-a-Phase-3-Trial-for-the-Treatment-of-Early-Alzheimer%E2%80%99s-Disease
May 14, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next